Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2012
04/19/2012US20120095037 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095036 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
04/19/2012US20120095034 Piperidine derivatives useful as orexin receptor antagonists
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095028 3-oxa-7-azabicyclo[3.3.1]nonanes
04/19/2012US20120095022 Derivatives of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-ones, method for preparation thereof and therapeutic uses thereof
04/19/2012US20120095017 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
04/19/2012US20120095016 Therapeutic 5,6,5-tricyclic analogs
04/19/2012US20120095010 Tricyclic delta-opioid modulators
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120095001 Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
04/19/2012US20120094999 Egfr inhibitors and methods of treating disorders
04/19/2012US20120094984 Fused aminodihydrothiazine derivatives
04/19/2012US20120094983 Acyclic ikur inhibitors
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012US20120094968 Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094864 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
04/19/2012US20120094833 Herbicidal quinoline and 1,8 -naphthyridine compounds
04/19/2012US20120090684 Organic dye, composite dye and dye-sensitized solar cells using the same
04/19/2012DE102010042634A1 Neue Amin-substituierte tricyclische Fluoreszenzfarbstoffe New amine-substituted tricyclic fluorescent dyes
04/19/2012CA2819381A1 Method of making azaindazole derivatives
04/18/2012EP2440938A1 mCPP IMMUNOASSAY
04/18/2012EP2440557A1 Novel sterically hindered amine light stabilizers
04/18/2012EP2440554A1 Pyrazole oxadiazole derivatives as s1p1 agonists
04/18/2012EP2440544A1 Hedgehog pathway antagonists and therapeutic applications thereof
04/18/2012EP2440542A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
04/18/2012EP2440541A1 Novel fused cyclic compound and use thereof
04/18/2012EP2440204A1 Nicotinamide compounds useful as kinase modulators
04/18/2012EP2440203A1 Small molecule inhibitors of polynucleotide kinase/phosphatase. poly(adp-ribose) polymerase and uses thereof
04/18/2012EP2440054A1 Pyridil-triazine inhibitors of hedgehog signaling
04/18/2012EP2440048A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
04/18/2012EP2188286B1 Process for the preparation of pyrido [2, 1-a]isoquinoline derivatives
04/18/2012EP2121691B1 Spirocyclic cyclohexane derivatives
04/18/2012EP1807424B1 Novel kinase inhibitors
04/18/2012CN102421777A 作为hsl抑制剂的氮杂环螺衍生物 As hsl inhibitors spiro heterocyclic derivatives
04/18/2012CN102421776A Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
04/18/2012CN102421775A 抑制Raf激酶的吡咯并[2,3-b]吡啶衍生物 Inhibition of Raf kinase pyrrolo [2,3-b] pyridine derivatives
04/18/2012CN102421761A 二氨基杂环甲酰胺化合物 Diamino heterocyclic carboxamide compound
04/18/2012CN102421760A Dihydropyrimidinones for use as bace2 inhibitors
04/18/2012CN102421429A Selective ep4 receptor agonistic substance for treatment of cancer
04/18/2012CN102417508A 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症 A fused aryl and heteroaryl metabolic modulators aryl derivatives and the prevention and treatment of disorders associated therewith
04/18/2012CN102417480A Spirocyclic nitriles as protease inhibitors
04/18/2012CN101978962B 用于结肠癌的药物组合物及其有效单体的制备方法 Preparation of a pharmaceutical composition for colon cancer and its effective monomer
04/18/2012CN101636399B 可用作plk1抑制剂的取代的嘧啶并二氮杂* Plk1 substituted pyrimidine used as inhibitors benzodiazepine *
04/18/2012CN101591335B N-(l-氨基酰)-1,2,3,4-四氢咔啉酰氨基酸苄酯及其合成方法及应用 N- (l- amino acid), 2,3,4-tetrahydrocarboline amino acid benzyl ester synthesis method and its application
04/18/2012CN101362719B 喹啉类衍生物以及包含其的组合物 Quinoline derivatives and compositions containing them
04/18/2012CN101326183B 作为抗炎剂的二环杂环化合物 As an anti-inflammatory agent bicyclic heterocyclic compounds
04/17/2012US8158797 Oxazolidinone-quinolone hybrid antibiotics
04/17/2012US8158794 Hydroxyalkyl substituted imidazoquinoline compounds and methods
04/17/2012US8158649 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
04/17/2012US8158647 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
04/17/2012US8158646 Antifungal and antiparasitic indoloquinoline derivates
04/17/2012US8158634 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
04/17/2012US8158629 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
04/17/2012US8158622 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
04/17/2012US8158619 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
04/17/2012CA2582447C Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
04/17/2012CA2491680C Inhibitors of ftsz and uses thereof
04/17/2012CA2450007C Compounds and methods for the treatment or prevention of flavivirus infections
04/12/2012WO2012048222A1 FURO[3,2-d]PYRIMIDINE COMPOUNDS
04/12/2012WO2012048129A2 Inhibitors of polo-like kinase
04/12/2012WO2012047570A1 Fused tricyclic inhibitors of mammalian target of rapamycin
04/12/2012WO2012047569A1 Fused tricyclic inhibitors of mammalian target of rapamycin
04/12/2012WO2012046839A1 Benzo[k]fluoranthene derivative and organic electroluminescence element containing same
04/12/2012WO2012046132A1 Quinazoline compounds as sodium channel blockers
04/12/2012WO2012045729A1 Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
04/12/2012WO2012045124A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls
04/12/2012WO2012007345A3 Substituted imidazo[1,2-a]pyrimidines and -pyridines
04/12/2012WO2011149950A3 Bicyclic heteroaryl kinase inhibitors and methods of use
04/12/2012WO2011133039A3 Novel conjugates of cc-1065 analogs and bifunctional linkers
04/12/2012US20120088788 Substituted imidazoles as bombesin receptor subtype-3 modulators
04/12/2012US20120088763 Triazolopyridine derivatives and their therapeutic use
04/12/2012US20120088755 Novel Compounds
04/12/2012US20120088752 Hedgehog pathway antagonists and therapeutic applications thereof
04/12/2012US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
04/12/2012US20120088723 Selective ep4 receptor agonistic substance for treatment of cancer
04/12/2012US20120087978 Dosage forms of apixaban
04/12/2012US20120087975 Method of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound
04/12/2012US20120085997 Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound
04/12/2012CA2813704A1 Quinazoline compounds as sodium channel blockers
04/11/2012EP2438067A1 New compounds
04/11/2012EP2438066A2 PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES
04/11/2012EP2438065A1 Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization
04/11/2012EP2438064A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
04/11/2012EP2438063A1 1h-imidazo[4,5-c]quinolinone compounds, useful for the treatment of proliferative diseases
04/11/2012EP2438043A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/11/2012EP2437605A1 Substituted pyridopyrazines with a herbicidal action
04/11/2012EP2437600A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
04/11/2012EP1963319B1 Heteroarylpyrrolopyridinones active as kinase inhibitors
04/11/2012EP1724258B1 Heteroarylphenylurea derivative
04/11/2012EP1675552B1 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
04/11/2012EP1651612B1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
04/11/2012EP1532153B8 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
04/11/2012CN1900077B New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
04/11/2012CN102414211A 3-([1,2,3]三唑-4-基)吡咯并[2,3-b]吡啶衍生物 3 - ([1,2,3] triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
04/11/2012CN102414210A 作为β-分泌酶抑制剂的取代的咪唑并[1,2-a]吡啶衍生物、药物组合物和使用方法 -secretase Inhibitors as β- substituted imidazo [1,2-a] pyridine derivatives, pharmaceutical compositions and methods of use
04/11/2012CN102414195A Fused heterocyclic compound and use thereof
04/11/2012CN102414190A NF-kB的抑制剂 NF-kB inhibitors